STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.

Group 1 - Monteverde & Associates PC is investigating Longboard Pharmaceuticals, Inc. regarding a tender offer from H. Lundbeck A/S, which proposes to acquire outstanding shares of Longboard common stock for $60.00 per share [1] - Monteverde & Associates PC has been recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report, indicating its successful track record in recovering money for shareholders [1][2] - The firm operates from the Empire State Building in New York City and emphasizes its national presence in class action securities litigation [2] Group 2 - The firm encourages shareholders of Longboard Pharmaceuticals to reach out for additional information or concerns regarding the tender offer [3] - Contact information for Juan Monteverde, Esq. is provided for shareholders seeking legal assistance or more details about the case [4]